INFORMATIONAL PURPOSES ONLY. Not medical, legal, or travel advice. Verify with official sources before acting. See corrections log.

Medical Freedom Maps

Home » Maps » Right to try » North Dakota

Right to try in North Dakota

Right to try laws and requirements in North Dakota. Citations, verification dates, and source links for every data point.

DimensionValueCitationSourceVerifiedConfidence
Have Enacted State Right to Try Lawshave state RTT lawsN.D. Cent. Code § 23-48-02“A manufacturer of an investigational drug, biological product, or device may make available the manufacturer's investigational drug, biological product, or device to an eligible patient pursuant to this chapter.”Link2026-10-09high
Enacted Right to Try Laws Before Federal Law20152015 N.D. Sess. Laws, SB 2259 (codified at N.D. Cent. Code ch. 23-48)“AN ACT to create and enact chapter 23-48 of the North Dakota Century Code, relating to the use of experimental drugs; and to provide for a notification by the secretary of state.”Link2026-10-09high
Require Individualized Manufacturer Approval for RTTdo not require individualized approvalN.D. Cent. Code § 23-48-01“"Investigational drug, biological product, or device" means a drug, biological product, or device that has successfully completed phase one of a clinical trial but has not yet been approved for general use”Note: Stored true is not supported. ND's only RTT law (ch. 23-48) is the classic terminal-illness/phase-one model; no individualized-treatment provisions. Searched full ND bill indexes for 2019, 2021, 2023 and 2025 sessions (ndlegis.gov) for 'individualized', 'investigational', 'experimental drug', '23-48', 'right to try': no individualized-treatment bill found (ND has no regular session in 2026). ND is also not in the reported list of enacting states.Link2026-10-09high
Provide Manufacturer Liability Protection Under RTTprovide liability shieldN.D. Cent. Code § 23-48-05“This chapter does not create a private cause of action against a manufacturer of an investigational drug, biological product, or device or against any other person involved in the care of an eligible patient”Link2026-10-09high
Require Insurer Coverage of Investigational Treatmentsdo not require coverageN.D. Cent. Code §§ 23-48-01(4)(e), 23-48-04“States the patient's health insurer and provider are not obligated to pay for any care or treatments consequent to the use of the investigational drug, biological product, or device;”Link2026-10-09high

View full North Dakota profile (all layers) · Report an error on this page

Methodology: every value was checked in October 2026 against a specific source (statute, regulator or official list, or a named tracker page), and each links to that page with a short quote. Values no source could support are shown as “Not verified”. Verification was AI-assisted and spot-checked; laws change, so confirm with the linked source before relying on a value. How values are verified · Report an error.